Prelude Capital Management, LLC Assertio Holdings, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $13,419 - $30,299	5,325 Added 26.07%	25,751 $65,000
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $45,335 - $69,453	9,067 Added 79.82%	20,426 $110,000
Q1 2023 May 15, 2023	BUY	$3.54 - $6.66 $3,748 - $7,052	1,059 Added 10.28%	11,359 $72,000
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $21,939 - $41,200	10,300 New	10,300 $23,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.